Search results
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 16 hours agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Dow Jones Futures Fall: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Investor's Business Daily· 9 hours agoChipotle Mexican Grill, NXP Semiconductor, Texas Roadhouse and Tradeweb Markets — plus Dow Jones...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 23 hours agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Is Merck Stock Fully Valued At $130?
Forbes· 6 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 5 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoPRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region ...